Table 3.
Indication and use of gastroprotective drugs in patients admitted for non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy
| With gastroprotective criteria* |
No gastroprotective criteria |
||||||
|---|---|---|---|---|---|---|---|
| Mode of NSAID indication | Patients, n (%) | n (%) | With gastroprotection, n (%) | p Value | n (%) | With gastroprotection, n (%) | p Value |
| Medical prescription | 43 (69.4) | 34 (79.1) | 16† (47.1) | 0.345 | 9 (20.9) | 2 (22.2) | 0.086 |
| Self-medication | 19 (30.6) | 7 (36.8) | 2 (28.6) | 12 (63.2) | – | ||
*Patients with at least one of the following risk criteria (relevant risk factors): age >60 years (age risk factor); personal medical history of peptic ulcer with/without complication (history risk factor); and concomitant use of other NSAIDs, systemic corticosteroids, oral anticoagulants or platelet aggregation inhibitors (concomitant medication risk factor).
†In three of these patients some of the prescribed gastroprotective treatment containers were registered as ‘non-dispensed’ in the electronic medication history during NSAID intake.